简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-10-31 10:26 Janssen Presents Positive Long-Term Efficacy and Safety of SYMTUZA®▼ (D/C/F/TAF) in Treatment-Naïve Adults with HIV-1
2018-10-31 10:13 Nordson EFD Introduces Dial-A-Dose and Posi-Dose Animal Health Dosing Syringes
2018-10-30 17:46 Terns Pharmaceuticals Completes $80 Million Series B Financing to Advance Pipeline of Drugs to Treat NASH and Cancer
2018-10-30 14:32 Takeda Comments on Ongoing Phase 1 Review by the European Commission of the Proposed Acquisition of Shire plc
2018-10-29 19:28 Takeda to Highlight Data in Hodgkin Lymphoma During the 11th International Symposium on Hodgkin Lymphoma
2018-10-29 19:26 SpinalCyte Announces Positive 12 Month Pain Data From Phase 1/Phase 2 Clinical Trial for Degenerative Disc Disease
2018-10-29 19:23 Mitsui Chemicals and Chitose Group Launch Novel Open Innovation Initiative to Foster Businesses and Talents
2018-10-29 15:36 Takeda Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc
2018-10-26 14:12 Harvest Enterprises Inc. Announces Appointments of Elroy Sailor and Mark Barnard to Its Board of Directors
2018-10-26 14:06 PHC Holdings Announces Strategic Cooperation Agreement with Mitsui & Co., Ltd. and China Resources Healthcare Group Limited
2018-10-25 13:53 Eminent Scientist James Till Turned Philanthropist; Donates Prize Money to the Cause of Young Researchers
2018-10-25 13:41 Morinaga Milk Study Suggests Infant-Type Human-Residential Bifidobacteria May Benefit Infant Health by Improving Digestion of Peptides in Milk and Grains
2018-10-24 16:36 PotNetwork Holdings, Inc. Reports $18.1 Million in Sales Surpassing Entire Revenue Generated in 2017
2018-10-24 16:34 Mentice Appoints New Member to its Board of Directors.
2018-10-24 11:40 ResMed Wins German Patent Infringement Case Against Fisher & Paykel
2018-10-23 15:05 Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
2018-10-23 10:53 Philip Morris International Launches Next Generation of IQOS, the World’s Leading Heated Tobacco Product
2018-10-22 16:20 Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma
2018-10-22 13:43 Edogawa Niche Prize 2018 to Be Awarded to Prof. James Till for Stem Cell Discovery
2018-10-22 13:40 Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Business Wire Weibo

Press Releases

Latest Releases